Ramipril/felodipine
Alternative Names: Tazko; UnimaxLatest Information Update: 26 Aug 2004
At a glance
- Originator AstraZeneca; sanofi-aventis
- Class Antihypertensives; Dihydropyridines; Heterocyclic bicyclo compounds
- Mechanism of Action ACE inhibitors; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Essential hypertension
Most Recent Events
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 06 Sep 2000 Launched for Essential hypertension in Austria (PO)
- 22 Dec 1999 Hoechst Marion Roussel has merged with Rhône-Poulenc Rorer to form Aventis Pharma